Vakrangee consolidated net profit rises 15.98% in the March 2025 quarter

Capital Market Automatic

Used for treatment of HER2-positive metastatic and early breast cancers

CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys from EMA

L&T Finance consolidated net profit rises 14.86% in the March 2025 quarter

Bhansali Engineering Polymers consolidated net profit declines 2.28% in the March 2025 quarter

Vakrangee standalone net profit rises 178.22% in the March 2025 quarter

Force Motors reported a 209.93% surge in consolidated net profit to Rs 434.71 crore on a 17.14% rise in revenue from operations to Rs 2,356.01 crore in Q4 FY25 over Q4 FY24.

Force Motors Q4 PAT surges 210% YoY to Rs 435 cr; declares dividend of Rs 40/sh

Board of PTC India appoints Dr. Manoj Kumar Jhawar as CMD

Steel Authority of India announces cessation of director

Harsha Engineers International receives LoI for a contract of 5 years

Suven Pharmaceuticals announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, for foreign investment under applicable regulations. This marks the final regulatory clearance required to implement the Scheme of Amalgamation between Cohance Lifesciences and Suven Pharmaceuticals, a transaction previously approved by shareholders and sanctioned by the Hon'ble NCLT, Mumbai Bench. 

Suven Pharmaceuticals receives regulatory nod for scheme of amalgamation

Companies News: Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Company News: Company Business News, Indian Companies News, Company Analysis, Corporate Industry News

Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Duroply Industries Ltd News